Revance Therapeutics, Inc. (RVNC)
TN
Total Compensation for Fiscal Year Ending in 2023: $10,068,915
| Salary | $720,000 |
|---|---|
| Bonus | $0 |
| Value of Stock Awards | $8,810,731 |
| Value of Option Awards | $0 |
| Non-Equity Incentive Plan Compensation | $522,720 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $15,464 |
| Total | $10,068,915 |
Revance Therapeutics, Inc. disclosed its CEO pay was
42
times its median employee's pay for the fiscal year ending in 2023.
How Do You Compare?
